The Asia Group, LLC (“TAG”), a leading Washington-based strategic advisory firm supporting global businesses and investors across the Indo-Pacific, is proud to announce its efforts as principal strategic and sales advisor to a groundbreaking collaboration and licensed production agreement between Arcturus Therapeutics Holdings Inc. (ARCT) and Vinbiocare Biotechnology JSC (a member of Vingroup JSC).
The leading U.S-based cutting-edge vaccine and medicine development Arcturus has just announced that it will transfer its mRNA vaccine production technology to VinBioCare (a member of Vingroup).
Accordingly, the potential single shot mRNA vaccine is undergoing phase 2 clinical trials in the United States and Singapore, and promising clinical data demonstrates a favorable safety profile and both humoral and cellular immunogenicity against COVID-19. As part of this agreement, Arcturus will work with the Government of Vietnam to develop a phase 3 trial to further demonstrate ARCT-021′s safety profile and efficacy for the Vietnam market.
Behind this cutting-edge vaccine production technology transfer is The Asia Group (“TAG”) – the U.S-based premier strategic advisory firm. Specifically, TAG serves as the key strategic and sales advisor to the groundbreaking collaboration agreement to bring mRNA vaccine technology to Vietnam.
Mr. Nirav Patel, CEO and Co-Founder of TAG noted that: “TAG is excited to support our client’s strategic and commercial interests in one of the most dynamic markets in the world and in doing so providing the people of Vietnam with cutting edge vaccines to address the COVID-19 pandemic.”
Ms. Le Thi Thu Thuy, Vice Chairwoman of Vingroup said: “The Asia Group team led by Nirav Patel has proven instrumental in supporting critical commercial investments of the technology necessary to support the people of Vietnam and enabling Vingroup and Arcturus’ strategic and commercial partnership. We look forward to continuing to work with the TAG team as we look for new opportunities to expand our business.”
In addition to the vaccine production technology transfer project, The Asia Group is also known as the leading strategic advisory firm that has connected many foreign businesses to invest in Vietnam or support Vietnamese businesses to find investment opportunities in the global market.
Typically, The Asia Group is a long-term strategic partner of An Phat Holdings – a pioneer corporation in Vietnam in the production and research of environmentally friendly materials and products that meet international standards. Mr. Nirav Patel – CEO and Co-Founder of TAG is also a member of the Board of Directors of An Phat Holdings.
For years, The Asia Group and An Phat Holdings have collaborated on projects to develop and trade of green products. In which, An Phat Holdings is the manufacturer of green products and materials while TAG is responsible for seeking potential partners, penetrating and expanding the international market, especially the US and North American countries.
An Phat Holdings has also actively supported The Asia Group in successfully connecting this project.
